Company InformationQED Therapeutics was founded on January 2018. The company is based in Palo Alto, CA, USA . The number of employees in QED Therapeutics is less than 50. Qed therapeutics is a biotechnology company focused on precision medicine for fgfr-driven disorders.
Here is how QED Therapeutics describes itself: "Learn how QED Therapeutics is advancing the fight against cholangiocarcinoma and other FGFR-driven diseases through research and innovation."
Funding & investorsQED Therapeutics has received 1 rounds of venture funding. The total funding amount is around $65M.
Similar Companies [beta]
- Magenta therapeutics
- Cirius therapeutics
- Plakous therapeutics
- Clene nanomedicine
- Prelude therapeutics
- Eliem therapeutics
Active Venture Investors
- Active Investors in Biotechnology
- Active Investors in Health Care
- Active Investors in Science And Engineering
- Active Investors in Wellness
- Best Funded Biotechnology Startups
- Best Funded Health Care Startups
- Best Funded Science And Engineering Startups
- Best Funded Wellness Startups
QED Therapeutics - Blog